Endonovo Therapeutics
(OTC) ENDV
Endonovo Therapeutics Financials at a Glance
Market Cap
$180,800
Revenue (TTM)
$0.00
Net Income (TTM)
$2.46M
EPS (TTM)
$-0.01
P/E Ratio
-0.02
Dividend
$0.00
Beta (Volatility)
-4.96 (Low)
Dividend
$0.00
Beta (Volatility)
-4.96 (Low)
Price
$0.00
Volume
950,002
Open
$0.00
Price
$0.00
Volume
950,002
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
Dividend
$0.00
Beta (Volatility)
-4.96 (Low)
Price
$0.00
Volume
950,002
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.00
ENDV News
ENDV: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Endonovo Therapeutics
Industry
Biotechnology
Sector
Health CareCEO
Alan Brian Collier
Website
www.endonovo.comHeadquarters
Woodland Hills, CA 91367, US
ENDV Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
4%
Return on Assets
-137%
Earnings Yield
-50.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$180.80K
Shares Outstanding
1.81B
Volume
950.00K
Short Interest
0.00%
Avg. Volume
1.50M
Financials (TTM)
Gross Profit
$615.20K
Operating Income
$1.56M
EBITDA
$941.40K
Operating Cash Flow
$100.49K
Capital Expenditure
$3.00
Free Cash Flow
$100.49K
Cash & ST Invst.
$3.00
Total Debt
$6.87M
Endonovo Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
$0.00
+100.0%
Gross Margin
0.00%
N/A
Market Cap
$180.80K
N/A
Market Cap/Employee
$180.80K
N/A
Employees
1
N/A
Net Income
$557.90K
+22.7%
EBITDA
$248.56K
+0.7%
Quarterly Fundamentals
Net Cash
$6.90M
+1.7%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$6.90M
-1.7%
Return on Assets
-136.94%
N/A
Return on Invested Capital
4.42%
N/A
Free Cash Flow
$102.76K
-80.5%
Operating Cash Flow
$102.76K
-80.5%